Loading...

Pulmonary arterial hypertension (PAH) is a complex disease that requires timely diagnosis, individualized therapy, and coordinated care. PAHrmacology: Evidence in Action, a continuing pharmacy education activity, provides a practical, evidence-based foundation for managing PAH from initial evaluation through longterm treatment. Learners will review diagnostic and risk stratification approaches, compare available pharmacotherapy options, and explore real-world considerations such as medication initiation and transitions of care across clinical settings to support safe, continuous treatment.

Two researchers working with samples at a laboratory bench

Course Outline

Speaker and Disclosure 

Speaker 
Dalton Kuebel, PharmD, BCPP 
Clinical Pharmacy Specialist, Critical Care, UC Health University of Cincinnati Medical Center 

Disclosure 
The speaker and planning committee members have no relevant financial relationships with ineligible companies to disclose.

Learner Outcomes

Pharmacists who complete the course can expect the following learning outcomes: 

  1. Describe the diagnosis, risk stratification, and treatment pathway for pulmonary hypertension. 

  2. Distinguish pharmacotherapy options for pulmonary arterial hypertension (PAH), including mechanisms, indications, and clinical considerations. 

  3. Illustrate how to navigate transitions of care procedures for different PAH medications to optimize patient outcomes.

Who Should Register?

This course is designed for pharmacists who want to stay current on evidence-based, patient-centered approaches to managing pulmonary hypertension.

 

Additional Information

Requirements

Credit requirements must be completed before the expiration date of the activity. Participants must watch the video in its entirety and completion of a post-test with a score of 80% or higher. Upon completion, credit will be transmitted electronically to the ACPE. All transmitted credit will be viewable in your CPE Monitor profile within 24 hours. It is the participants' responsibility to ensure credit is properly populating on their individual NABP eProfile account. Please contact the James L. Winkle College of Pharmacy Continuing Pharmacy Education Office at (513) 558-4716 or RxCPD@uc.edu with questions or concerns.

The Office of Continuing Pharmacy Education has a formal grievance process to address any problems related to this activity or its administration. (Effective January 2008) Comments and/or concerns about this activity should be sent to the University of Cincinnati James L. Winkle College of Pharmacy, 3255 Eden Ave., Cincinnati, OH 45267-0004, Attention: Dr. Karissa Kim. Questions about Continuing Pharmacy Education credit may be forwarded to this address. The CPE Office can be reached at (513) 558-4716 or via email at RxCPD@UC.edu.
 

Minimum System Requirements
Processor: 1 GHz
Hard Drive: 32 GB
Memory (RAM): 1 GB
Sound card w/speakers
Internet Access: 10 Mbps download
Supported Browsers
Latest Chrome Version
Latest Firefox Version
Latest Edge Version
Latest Safari Version
Internet Explorer 11
Loading...

Select a section to register

Section Title
PAH-rmacology: Evidence in Action
Type
Online Self-Paced (Non-Facilitated)
Duration
Feb 16, 2026 to Feb 16, 2029
Cost

Section Notes

PAH-rmacology: Evidence in Action 
Contact Hours: 1.25 hours 
UAN: 0050-0000-26-009-H01-P 
Activity Type: Knowledge 
Setting: Home 
Target Audience: Pharmacist 
Released: 2026-02-16 
Expires: 2029-02-16 

Note: In the confirmation email, learners will receive a link to register and complete the activity 
 

The University of Cincinnati James L. Winkle College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Required fields are indicated by .